Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AB-1005 by Asklepios BioPharmaceutical for Parkinson's Disease: Likelihood of Approval
AB-1005 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...
Data Insights
AB-1005 by Asklepios BioPharmaceutical for Parkinson's Disease: Likelihood of Approval
AB-1005 is under clinical development by Asklepios BioPharmaceutical and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...